Company / Working Capital per Share
Pacira BioSciences, Inc. Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$9.24
FY2025
5-year range
$7.84 / $9.41
FY2021-FY2025
Trend
-1.8%
vs FY2024
Sector context
#55 of 210
Health Care
What the data says
At $9.24, Pacira BioSciences, Inc.'s working capital per share ranks #55 of 210 in the Health Care sector. Working Capital per Share has fluctuated over the past 10 years, ranging from $5.38 in FY2016 to $10.26 in FY2018.
Based on SEC 10-K filings.
9.24 in FY2025 with a 5-year CAGR of -0.6%.
Improved from $8.98 to $9.24 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- +5.7%
- 5-Year CAGR
- -0.6%
- 10-Year CAGR
- -
Sector benchmark
#55 of 210 in Health CareTop 26% of 210This company $9.24 Sector average $118.60
▼
-92.2% below sector average
Key checks
Key Insights
- In FY2025, working capital per share decreased 1.8% year-over-year.
- Ranks #55 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2018.
- Lowest working capital per share in the period was in FY2016.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Negative profit margin: -14.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.24 | -1.8% |
| FY2024 | $9.41 | +4.8% |
| FY2023 | $8.98 | +14.6% |
| FY2022 | $7.84 | -0.9% |
| FY2021 | $7.90 | -16.8% |
| FY2020 | $9.50 | +30.2% |
| FY2019 | $7.30 | -28.9% |
| FY2018 | $10.26 | +14.8% |
| FY2017 | $8.94 | +66.1% |
| FY2016 | $5.38 | +89.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026